相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003
Astri Fjelde Maaland et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab
Ruby F. Meredith et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
Benjamin B. Kasten et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
Benjamin B. Kasten et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia
Carmen D. Herling et al.
NATURE COMMUNICATIONS (2018)
Affinity of human IgG subclasses to mouse Fc gamma receptors
Gillian Dekkers et al.
MABS (2017)
B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models
Benjamin B. Kasten et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
Diane E. Milenic et al.
TRANSLATIONAL ONCOLOGY (2017)
Metal-Free Cycloaddition Chemistry Driven Pretargeted Radioimmunotherapy Using α-Particle Radiation
Manankumar A. Shah et al.
BIOCONJUGATE CHEMISTRY (2017)
Targeted Radionuclide Therapy of Human Tumors
Sergey V. Gudkov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Phase I Trial of Targeted Alpha-Particle Therapy with Actinium-225 (225Ac)-Lintuzumab and Low-Dose Cytarabine (LDAC) in Patients Age 60 or Older with Untreated Acute Myeloid Leukemia (AML)
Joseph G. Jurcic et al.
BLOOD (2016)
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
B. Eichhorst et al.
ANNALS OF ONCOLOGY (2015)
Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease
Diane E. Milenic et al.
MABS (2015)
Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody-Drug Conjugates
Patrick Dennler et al.
BIOCONJUGATE CHEMISTRY (2014)
Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice
Kyung Pyo Kang et al.
MOLECULAR MEDICINE REPORTS (2014)
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model
K. A. Beckwith et al.
LEUKEMIA (2014)
Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
Jutta Deckert et al.
BLOOD (2013)
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
Daryl Tan et al.
BLOOD (2013)
Biodistribution of 212Pb conjugated trastuzumab in mice
N. R. Schneider et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2013)
Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using 212Pb
Vincent Boudousq et al.
PLOS ONE (2013)
Crosstalk between Human IgG Isotypes and Murine Effector Cells
Marije B. Overdijk et al.
JOURNAL OF IMMUNOLOGY (2012)
Rituximab resistance
Andrew R. Rezvani et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2011)
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies
Karl-Heinz Heider et al.
BLOOD (2011)
Site-Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase
Simone Jeger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
Todd L. Rosenblat et al.
CLINICAL CANCER RESEARCH (2010)
Glomerular Filtration Rate After Alpha-Radioimmunotherapy with 211At-MX35-F(ab′)2: A Long-Term Study of Renal Function in Nude Mice
Tom Back et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator
FM Su et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
α-particle radioimmunotherapy of disseminated peritoneal disease using a 212Pb-labeled radioimmunoconjugate targeting HER2
DE Milenic et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
Melanoma therapy via peptide-targeted α-radiation
YB Miao et al.
CLINICAL CANCER RESEARCH (2005)
Targeted at particle immunotherapy for myeloid leukemia
JG Jurcic et al.
BLOOD (2002)
Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site
JA Nemzek et al.
INFLAMMATION RESEARCH (2001)
分享论文
